Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs

Brenda Richards(Sequenom (United States)), K. Klinger(Sanofi (France)), Henry L. Dorkin(Boston Children's Hospital), Joel Skoletsky(Sequenom (United States)), Richard B. Parad(Brigham and Women's Hospital), Robert C. Stern(Rainbow Babies & Children's Hospital), Anthony P. Shuber(Exact Sciences (United States)), David R. Witt(Kaiser Permanente), Rosemary Balfour(Sequenom (United States))
Human Molecular Genetics
January 1, 1993
10.1093/hmg/2.2.159
Cited by 414

Related Papers

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|458
Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project
|The American Journal of Human Genetics|2019|307
Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial
|Human Gene Therapy|2007|275
Airway area by acoustic reflections measured at the mouth
|Journal of Applied Physiology|1980|250